---
$id: https://graph.org.ai/products/commodity/51162708
$type: Product
source: UNSPSC
code: "51162708"
title: "Domiodol"
class: "51162700"
classTitle: "Decongestants, expectorants, and mucolytics"
family: "51160000"
familyTitle: "Drugs affecting the respiratory tract"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Domiodol

**UNSPSC Code**: 51162708
**Class**: [Decongestants, expectorants, and mucolytics](Decongestants, expectorants, and mucolytics.mdx)
**Family**: [Drugs affecting the respiratory tract](../Drugs affecting the respiratory tract.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a mucolytic agent with the molecular formula C5H9IO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) C1PXF8V06N, chemically known as 1,3-dioxolane-4-methanol, 2-(iodomethyl)-, (e,z)- but more generally known as domiodol, which bears US NIH Compound Identifier 43814. European Medicines Agency schedules Domiodol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06355MIG. The term DOMIODOL is an International Non-Proprietary Name. World Health Organization schedules domiodol in its Anatomical Therapeutic Chemical (ATC) Classification. DOMIODOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule domiodol under HS 29329970 and SITC 51569. As of Q4 2014, DOMIODOL remains US FDA's Preferred Term for this commodity. Domiodol bears US NLM identifiers UMLS ID C0048365 and NCI Concept Code C65461. SMILES: ICC1OC(CO1)CO.

